growth failure |
Disease ID | 1823 |
---|---|
Disease | growth failure |
Definition | A condition of substandard growth or diminished capacity to maintain normal function. |
Synonym | [d]failure to thrive [d]failure to thrive (context-dependent category) [d]failure to thrive (situation) failure to thrive failure to thrive (disorder) failure to thrive [disease/finding] failure to thrive syndrome failure to thrive-child failure-to-thrive ftt - failure to thrive thrive, failure to |
UMLS | C0015544 |
MeSH | |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:38) C0013338 | growth hormone deficiency | 3 C0025958 | microcephaly | 2 C0038015 | spondyloepiphyseal dysplasia | 2 C0010674 | cystic fibrosis | 2 C0024523 | malabsorption | 2 C0023473 | chronic myeloid leukemia | 1 C0039730 | thalassemia | 1 C0221406 | cushing disease | 1 C0020676 | hypothyroidism | 1 C0751651 | mitochondrial disease | 1 C0001768 | agammaglobulinemia | 1 C0162429 | nutritional deficiencies | 1 C0162429 | malnourished | 1 C0002871 | anemia | 1 C0022658 | renal disease | 1 C0152021 | congenital heart disease | 1 C0162429 | malnutrition | 1 C0023470 | myeloid leukemia | 1 C0035078 | renal failure | 1 C0009319 | colitis | 1 C0006625 | cachectic | 1 C0035579 | rickets | 1 C0020676 | hypothyroid | 1 C0014130 | endocrinopathy | 1 C0002895 | sickle-cell disease | 1 C0022661 | end-stage renal disease | 1 C0026850 | muscular dystrophy | 1 C0018799 | heart disease | 1 C0041296 | tuberculosis | 1 C0011849 | diabetes mellitus | 1 C0004775 | bartter syndrome | 1 C0023418 | leukemia | 1 C0039730 | thalassaemia | 1 C0037315 | sleep disordered breathing | 1 C0022661 | chronic renal failure | 1 C0021831 | enteropathy | 1 C0028754 | obesity | 1 C0751651 | mitochondrial diseases | 1 |
Curated Gene | (Waiting for update.) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 1823 |
---|---|
Disease | growth failure |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:3) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:2) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs386601896 | 17848410 | 2908 | NR3C1 | umls:C0015544 | BeFree | The 23K variant of the R23K polymorphism in the glucocorticoid receptor gene protects against postnatal growth failure and insulin resistance after preterm birth. | 0.000271442 | 2007 | NA | NA | NA | NA | NA |
rs386601896 | 17848410 | 2908 | NR3C1 | umls:C0878787 | BeFree | The 23K variant of the R23K polymorphism in the glucocorticoid receptor gene protects against postnatal growth failure and insulin resistance after preterm birth. | 0.000271442 | 2007 | NA | NA | NA | NA | NA |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:2) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0015544 | reserpine | D012110 | 50-55-5 | failure to thrive | MESH:D005183 | marker/mechanism | 6519379 | ||
C0015544 | zidovudine | D015215 | 30516-87-1 | failure to thrive | MESH:D005183 | marker/mechanism | 17304745 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |